TY - ADVS TI - Development of a cancer drug AU - Edelman, Martin PY - 2022 DA - 2022/05/31 UR - https://hstalks.com/bs/4964/ AB - Requirements for drug approval in the U.S., Legal evolution of drug approval, The FDA and oncology drugs, Clinical trial phases, The effectiveness requirement, Traditional and new approaches to trial design, Types of controls, Targeted therapies, Companion diagnostics, Endpoints for oncology trials, Types of drug approval, New drug application (NDA), Biomarkers, FDA reviews and approvals DB - The Biomedical & Life Sciences Collection SN - 2056-452X ID - 5766 PB - Henry Stewart Talks ER -